- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Middle East Pharmaceutical Industries Company SJSC (4016)
Middle East Pharmaceutical Industries Company SJSC stock price live, this page displays TADAWUL 4016 stock exchange data. View the 4016 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Middle East Pharmaceutical Industries Company SJSC real time stock price chart below.
What Is the Middle East Pharmaceutical Industries Company SJSC Stock Price Today?
The Middle East Pharmaceutical Industries Company SJSC stock price today is 62.20.
What Is the Stock Symbol for Middle East Pharmaceutical Industries Company SJSC?
The stock symbol for Middle East Pharmaceutical Industries Company SJSC is "4016."
What Stock Exchange Does Middle East Pharmaceutical Industries Company SJSC Trade On?
Middle East Pharmaceutical Industries Company SJSC is listed and trades on the Saudi Arabia stock exchange.
Is Middle East Pharmaceutical Industries Company SJSC a Good Stock to Buy?
Determining whether Middle East Pharmaceutical Industries Company SJSC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4016 quote. (ISIN: SA160G51UO10)
What Is the Middle East Pharmaceutical Industries Company SJSC Stock Price Today?
The Middle East Pharmaceutical Industries Company SJSC stock price today is 62.20.
What Is the Stock Symbol for Middle East Pharmaceutical Industries Company SJSC?
The stock symbol for Middle East Pharmaceutical Industries Company SJSC is "4016."
What Stock Exchange Does Middle East Pharmaceutical Industries Company SJSC Trade On?
Middle East Pharmaceutical Industries Company SJSC is listed and trades on the Saudi Arabia stock exchange.
Is Middle East Pharmaceutical Industries Company SJSC a Good Stock to Buy?
Determining whether Middle East Pharmaceutical Industries Company SJSC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4016 quote. (ISIN: SA160G51UO10)
62.20
-0.95(-1.50%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
61.90
63.30
52 wk Range
53.89
79.09
4016 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
61.9063.30
52 wk Range
53.8979.09
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.50%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.50%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4016 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
146.40
Upside
+135.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 146.40
(+135.37% Upside)
Earnings
Latest Release
Aug 06, 2026
EPS / Forecast
0.82 / --
Revenue / Forecast
132M / --
Compare 4016 to Peers and Sector
Metrics to compare | 4016 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4016PeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.1x | 12.0x | −0.3x | |
PEG Ratio | 1.19 | 0.51 | 0.00 | |
Price/Book | 4.9x | 2.0x | 2.6x | |
Price / LTM Sales | 4.3x | 2.3x | 3.0x | |
Upside (Analyst Target) | 135.4% | 26.7% | 58.6% | |
Fair Value Upside | Unlock | 13.5% | 8.4% | Unlock |
Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infective, musculoskeletal, genitourinary system, and CNS products. It exports its products. The company has a collaboration with Bio-Thera Solutions, Ltd. to develop BAT2406, a biosimilar of Dupixent (dupilumab), a fully human monoclonal IgG4 antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling by specifically binding to the IL-4 receptor subunit (IL-4R), a subunit shared by the IL-4 and IL-13 receptor complexes. The company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Middle East Pharmaceutical (4016) Stock Price Today?
The Middle East Pharmaceutical stock price today is 62.20 SAR.
What Stock Exchange Does Middle East Pharmaceutical Trade On?
Middle East Pharmaceutical is listed and trades on the Saudi Arabia Stock Exchange.
What Is the Stock Symbol for Middle East Pharmaceutical?
The stock symbol for Middle East Pharmaceutical is "4016."
Does Middle East Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Middle East Pharmaceutical dividend yield is 2.5%.
What Is the Middle East Pharmaceutical Market Cap?
As of today, Middle East Pharmaceutical market cap is 2.18B SAR.
What Is Middle East Pharmaceutical's Earnings Per Share (TTM)?
The Middle East Pharmaceutical EPS (TTM) is 3.10.
When Is the Next Middle East Pharmaceutical Earnings Date?
Middle East Pharmaceutical will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is 4016 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Middle East Pharmaceutical Stock Split?
Middle East Pharmaceutical has split 1 times.
How Many Employees Does Middle East Pharmaceutical Have?
Middle East Pharmaceutical has 731 employees.
What is the current trading status of Middle East Pharmaceutical (4016)?
As of Oct 03, 2026, Middle East Pharmaceutical (4016) is trading at a price of 62.20 SAR, with a previous close of 63.15 SAR. The stock has fluctuated within a day range of 61.90 SAR to 63.30 SAR, while its 52-week range spans from 53.89 SAR to 79.09 SAR.
What Is Middle East Pharmaceutical (4016) Price Target According to Analysts?
The average 12-month price target for Middle East Pharmaceutical is 146.40 SAR, with a high estimate of 146.4 SAR and a low estimate of 146.4 SAR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +135.37% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.